Want to create an interactive transcript for this episode?
Podcast: Talking Euretina
Episode: Episode 79: Decoding Stargardt: New Treatments, Genetics, and What Lies Ahead
Description: A landmark Phase 3 trial has delivered the first positive result for Stargardt disease treatment — but the therapeutic landscape is shifting fast. Prof. Maximilian Pfau enjoys a discussion with Prof. Carel Hoyng and Dr. Karolina Kaminska on the ABCA4 disease spectrum, the groundbreaking discovery of AP5 complex-related macular dystrophy, and emerging therapies from oral drugs to gene-specific approaches